Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
In the latest session, Iterum Therapeutics Plc (NASDAQ: ITRM) closed at $0.67 down -3.86% from its previous closing price of $0.7. In other words, the price has decreased by -$3.86 from its previous closing price. On the day, 0.99 million shares were traded. ITRM stock price reached its highest trading level at $0.7299 during the session, while it also had its lowest trading level at $0.6714.
Ratios:
For a deeper understanding of Iterum Therapeutics Plc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.52 and its Current Ratio is at 2.69.
On March 15, 2021, H.C. Wainwright Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $2.50.
RBC Capital Mkts Downgraded its Outperform to Sector Perform on June 02, 2020, whereas the target price for the stock was revised from $7 to $2.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 08 ’25 when Dunne Michael W. bought 15,000 shares for $0.72 per share. The transaction valued at 10,854 led to the insider holds 235,001 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ITRM now has a Market Capitalization of 32400896 and an Enterprise Value of 49644152.
Stock Price History:
The Beta on a monthly basis for ITRM is 3.07, which has changed by -0.39821428 over the last 52 weeks, in comparison to a change of 0.13837254 over the same period for the S&P500. Over the past 52 weeks, ITRM has reached a high of $3.02, while it has fallen to a 52-week low of $0.61. The 50-Day Moving Average of the stock is -6.09%, while the 200-Day Moving Average is calculated to be -37.25%.
Shares Statistics:
For the past three months, ITRM has traded an average of 879.42K shares per day and 1118470 over the past ten days. Insiders hold about 2.19% of the company’s shares, while institutions hold 4.53% stake in the company. Shares short for ITRM as of 1759190400 were 1271626 with a Short Ratio of 1.45, compared to 1756425600 on 1216602. Therefore, it implies a Short% of Shares Outstanding of 1271626 and a Short% of Float of 2.87.
Earnings Estimates
A detailed examination of Iterum Therapeutics Plc (ITRM) is currently in progress, with 1.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is $0.01, with high estimates of $0.01 and low estimates of $0.01.
Analysts are recommending an EPS of between -$0.33 and -$0.33 for the fiscal current year, implying an average EPS of -$0.33. EPS for the following year is -$0.09, with 2.0 analysts recommending between $0.1 and -$0.27.
Revenue Estimates
Based on 2 analysts’ estimates, the company’s revenue will be $16.3M in the next fiscal year. The high estimate is $17.5M and the low estimate is $15.1M.
